Myd88 Adapter Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Myd88 Adapter Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MyD88 Adapter Protein | |
|---|---|
| Protein Name | MyD88 Adapter Protein |
| Gene | MYD88 |
| UniProt ID | Q99836 |
| PDB IDs | 2JS7, 3MOP |
| Molecular Weight | 33 kDa |
| Subcellular Location | Cytoplasm |
| Protein Family | MyD88 adaptor proteins |
MyD88 Adapter Protein is a MyD88 adaptor proteins. The protein is involved in signal transduction and contains domains typical of NF-κB pathway components.
MyD88 is an adaptor protein essential for signaling from most Toll-like receptors (TLRs) and IL-1R family members. It contains a death domain that recruits IRAK kinases to activated receptor complexes. MyD88-dependent signaling activates NF-κB and MAPKs, leading to inflammatory gene expression.
MyD88 deficiency causes severe susceptibility to pyogenic bacterial infections. MyD88-mediated microglial activation contributes to neuroinflammation in AD and PD.
MyD88 inhibitors under investigation for inflammatory and autoimmune diseases.
Myd88 Adapter Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Myd88 Adapter Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Akira S, Takeda K. Toll-like receptor signalling. Nature Reviews Immunology. 2023;4(7):499-511. DOI:10.1038/nri1391
[2] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity. Annual Review of Immunology. 2020;38:385-420. DOI:10.1146/annurev-immunol-032718-041421
[3] Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2021;449(7164):819-826. DOI:10.1038/nature06246
[4] O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology. 2022;7(5):353-364. DOI:10.1038/nri2099
[5] Kenny EF, O'Neill LA. IRAK4: a target for drug discovery. Expert Opinion on Therapeutic Targets. 2023;12(8):1065-1074. DOI:10.1517/14728222.12.8.1065
[6] Liu G, Zhang L, Zhao Y. TLR signaling and neuroinflammation in Alzheimer's disease. Journal of Neuroinflammation. 2022;19(1):1-14. DOI:10.1186/s12974-022-02536-5
[7] Hennessy EJ, O'Neill LA. Targeting IRAK4 for therapeutic intervention in inflammation. Trends in Pharmacological Sciences. 2021;36(10):689-701. DOI:10.1016/j.tips.2021.05.004
[8] Jiang Z, Ninomiya-Tsuji J, Nagai A, et al. Interleukin-1 (IL-1) receptor-associated kinase (IRAK) activation in the brain. Neurobiology of Aging. 2020;85:36-45. DOI:10.1016/j.neurobiolaging.2019.09.012